End-stage renal disease prevention strategies in Latin America

Slides:



Advertisements
Similar presentations
Volume 68, Issue 5, Pages (November 2005)
Advertisements

Stephen P. McDonald, Graeme R. Russ  Kidney International 
Optimization of pre-ESRD care: The key to improved dialysis outcomes
Volume 68, Pages S46-S52 (August 2005)
MariLia Bahiense Oliveira, Joao Egidio Romao, Roberto Zatz 
Anemia management in chronic kidney disease
Mitchell H. Rosner, W. Kline Bolton  Kidney International 
No difference in bleeding risk between subcutaneous enoxaparin and heparin for thromboprophylaxis in end-stage renal disease  Kevin E. Chan, Ravi I. Thadhani,
End-stage renal disease in developing countries
Volume 83, Issue 3, Pages (March 2013)
Anemia treatment in chronic kidney disease accompanied by diabetes mellitus or congestive heart failure  Steven Fishbane, Nobuyuki Miyawaki  Kidney International 
Volume 68, Issue 5, Pages (November 2005)
Volume 75, Issue 3, Pages (February 2009)
Volume 63, Issue 6, Pages (June 2003)
Volume 70, Issue 6, Pages (September 2006)
Kidney transplantation in a low-resource setting: Nigeria experience
Progression of renal failure and hypertensive nephrosclerosis
Mortality caused by sepsis in patients with end-stage renal disease compared with the general population  Mark J. Sarnak, Bertrand L. Jaber  Kidney International 
Section 5: Dialysis Interventions for Treatment of AKI
Burden of chronic kidney disease: North Africa
Haiyan Wang, Luxia Zhang, Jicheng Lv  Kidney International 
Francesco Paolo Schena  Kidney International 
Need for better diabetes treatment for improved renal outcome
Volume 70, Pages S21-S25 (December 2006)
Volume 66, Issue 3, Pages (September 2004)
Volume 80, Issue 9, Pages (November 2011)
Anemia as a risk factor for chronic kidney disease
Comorbidity and confounding in end-stage renal disease
Volume 70, Issue 11, Pages (December 2006)
Volume 67, Issue 4, Pages (April 2005)
Fernando Valderrábano, Francisco Gómez-Campderá, Elizabeth H.P. Jones 
The epidemiology of chronic kidney disease
Stephen P. McDonald  Kidney International Supplements 
Volume 68, Pages S46-S52 (August 2005)
Volume 70, Issue 12, Pages (December 2006)
Volume 67, Pages S48-S51 (January 2005)
Volume 76, Issue 5, Pages (September 2009)
Volume 68, Pages S4-S10 (August 2005)
Volume 76, Issue 6, Pages (September 2009)
American Journal of Kidney Diseases
Yijian Huang, Rebecca Zhang, Steven D. Culler, Nancy G. Kutner 
Volume 76, Issue 3, Pages (August 2009)
Extracorporeal therapy in sepsis: are we there yet?
Microbiology and outcomes of peritonitis in North America
Nephrology in Latin America, with special emphasis on Brazil
Racial disparities in access to transplantation: a tough nut to crack
The global challenge of chronic kidney disease
V.R. Sørensen, P.M. Hansen, J. Heaf, B. Feldt-Rasmussen 
Lynda Anne Szczech, Ira L. Lazar  Kidney International 
Volume 74, Issue 5, Pages (September 2008)
A practical approach to the treatment of depression in patients with chronic kidney disease and end-stage renal disease  S. Susan Hedayati, Venkata Yalamanchili,
Volume 73, Pages S72-S75 (April 2008)
Mortality, malnutrition, and atherosclerosis in ESRD: What is the role of interleukin-6?  Peter Stenvinkel, Peter Barany, Olof Heimbürger, Roberto Pecoits-Filho,
Volume 81, Issue 9, Pages (May 2012)
Stephen P. McDonald, Graeme R. Russ  Kidney International 
Volume 64, Issue 2, Pages (August 2003)
Opportunities for a chronic disease outreach program in China
Unraveling the racial disparities associated with kidney disease1
Peritoneal dialysis in Mexico
Taking a public health approach to the prevention of end-stage renal disease: The NKF Singapore Program  Sylvia Paz B. Ramirez, Stephen I-Hong Hsu, William.
Volume 76, Issue 6, Pages (September 2009)
Volume 63, Issue 2, Pages (February 2003)
The Iranian model of living renal transplantation
Early detection and prevention of diabetic nephropathy: A challenge calling for mandatory action for Mexico and the developing world  Ricardo Correa-Rotter,
Charles A. Herzog  Kidney International 
Renal replacement therapy in Latin America
Douglas E. Schaubel, Howard I. Morrison, Stanley S.A. Fenton 
Giuseppe Remuzzi, Carlos Chiurchiu, Piero Ruggenenti 
Volume 70, Issue 10, Pages (November 2006)
Optimization of pre-ESRD care: The key to improved dialysis outcomes
Presentation transcript:

End-stage renal disease prevention strategies in Latin America Bernardo RodriGuez-Iturbe, Ezequiel Bellorin-Font  Kidney International  Volume 68, Pages S30-S36 (September 2005) DOI: 10.1111/j.1523-1755.2005.09806.x Copyright © 2005 International Society of Nephrology Terms and Conditions

Figure 1 Life expectancy is correlated with GDP per capita. Shaded square denotes the mean and 95% confidence interval of these values in the sample of industrialized countries chosen for comparison (see text). Kidney International 2005 68, S30-S36DOI: (10.1111/j.1523-1755.2005.09806.x) Copyright © 2005 International Society of Nephrology Terms and Conditions

Figure 2 Mumber of medical doctors and nurses in LA compared with the corresponding number in industrialized countries. Dotted lines indicate the 95% confidence interval in industrialized countries; only 1 country (Jamaica) is within those limits. The rest of the countries are well below these limits, and 1 country (Cuba) has more health personnel than in the sample of industrialized countries. Kidney International 2005 68, S30-S36DOI: (10.1111/j.1523-1755.2005.09806.x) Copyright © 2005 International Society of Nephrology Terms and Conditions

Figure 3 The national expenditure in health is shown as a percentage of the GDP (A) and in US dollars per capita (B). Dotted lines represent the 95% confidence interval in industrialized countries. Kidney International 2005 68, S30-S36DOI: (10.1111/j.1523-1755.2005.09806.x) Copyright © 2005 International Society of Nephrology Terms and Conditions

Figure 4 Yearly increment of patients in all modalities of treatment for ESRD. In 2005, it is projected that LA will have 450 patients pmp on renal replacement therapies. Kidney International 2005 68, S30-S36DOI: (10.1111/j.1523-1755.2005.09806.x) Copyright © 2005 International Society of Nephrology Terms and Conditions

Figure 5 Etiology of patients on chronic dialysis in LA. Hypertension (32%) and diabetic nephropathy (33%) make up two thirds of patients. Kidney International 2005 68, S30-S36DOI: (10.1111/j.1523-1755.2005.09806.x) Copyright © 2005 International Society of Nephrology Terms and Conditions

Figure 6 Low birth weight in LA. The mean incidence of live births of less than 2500g is 2 times higher than that in industrialized countries. Kidney International 2005 68, S30-S36DOI: (10.1111/j.1523-1755.2005.09806.x) Copyright © 2005 International Society of Nephrology Terms and Conditions

Figure 7 Total per capita expenditure in health in LA is contrasted with calculated direct costs estimated to be caused by diabetes. Kidney International 2005 68, S30-S36DOI: (10.1111/j.1523-1755.2005.09806.x) Copyright © 2005 International Society of Nephrology Terms and Conditions